Autolus Therapeutics reported a gross margin of 55.20% and a net margin of -85.60% for the quarter ended Jun 2026. These financial ratios cover 34 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2017 | Dec2017 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | -39,165.52% | -99.86% | -16.83% | -35.15% | -4.29% | 55.20% | |||||||||||||||||||||||||||
| EBT Margin | -2,623.09% | -16,684.75% | -22,342.17% | -1,805.49% | -203.03% | -3,082.43% | -11,298.03% | -522.23% | -90,151.72% | -756.36% | -227.12% | -370.79% | -376.78% | -84.58% | ||||||||||||||||||||
| EBIT Margin | -2,503.19% | -17,099.58% | -21,798.80% | -1,576.49% | -318.39% | -3,030.03% | -10,567.73% | -384.07% | -261,600.00% | -726.34% | -292.58% | -337.93% | -298.35% | -95.95% | ||||||||||||||||||||
| EBITDA Margin | -2,503.19% | -17,099.58% | -21,798.80% | -1,576.49% | -318.39% | -3,030.03% | -10,567.73% | -384.07% | -261,600.00% | -726.34% | -292.58% | -337.93% | -298.35% | -95.95% | ||||||||||||||||||||
| Operating Margin | -2,503.19% | -17,099.58% | -21,798.80% | -1,576.49% | -318.39% | -3,030.03% | -10,567.73% | -384.07% | -261,600.00% | -726.34% | -292.58% | -337.93% | -298.35% | -95.95% | ||||||||||||||||||||
| Net Margin | -2,201.26% | -14,402.97% | -22,326.51% | -1,805.28% | -737.33% | -3,081.35% | -11,292.86% | -522.15% | -95,193.10% | -781.13% | -229.02% | -373.30% | -372.02% | -85.60% | ||||||||||||||||||||
| FCF Margin | -2,529.66% | -16,360.17% | -21,566.87% | -1,570.16% | -415.39% | -3,568.96% | -10,267.49% | -406.99% | -169,124.14% | -933.07% | -382.63% | -341.17% | -273.53% | |||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 9.39M | 19.30M | 25.83M | 30.47M | 33.32M | |||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 340.20M | 313.65M | 351.10M | 384.78M | 338.99M | 288.90M | 377.05M | 475.12M | 455.48M | 428.55M | 390.74M | 638.41M | 877.53M | 840.55M | 805.11M | 764.53M | 733.66M | 691.46M | 625.51M | 541.15M | ||||||||||||||
| Invested CapitalInvested Cap. | ||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.07 | 0.12 | 0.21 | ||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -20.90 | -20.22 | -21.58 | -20.19 | -3.37 | -7.98 | -8.84 | -8.56 | -1.77 | -2.01 | -5.79 | -6.35 | 2.46 | -6.43 | 8.96 | -6.81 | -3.17 | 16.39 | ||||||||||||||||
| Debt Ratio | ||||||||||||||||||||||||||||||||||
| Times Interest Earned | -20.90 | -20.22 | -21.58 | -20.19 | -3.37 | -7.98 | -8.84 | -8.56 | -1.77 | -2.01 | -5.79 | -6.35 | 2.46 | -6.43 | 8.96 | -6.81 | -3.17 | 16.39 | ||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -28.28 | -27.22 | -22.38 | -20.23 | -12.10 | -9.01 | -18.45 | -12.11 | -13.72 | -13.36 | -21.95 | -42.97 | -21.20 | -15.70 | -30.22 | -7.84 | -16.89 | -7.31 | -7.82 | -14.52 | ||||||||||||||
| Price to SalesP/S | 622.47 | 0.00M | 0.00M | 162.65 | 136.05 | 373.13 | 0.00M | 224.36 | 0.03M | 61.27 | 38.69 | 27.31 | 29.09 | 12.43 | ||||||||||||||||||||
| Price to BookP/B | 3.31 | 3.78 | 2.98 | 2.77 | 2.37 | 2.39 | 1.67 | 1.81 | 2.73 | 3.39 | 15.20 | 3.89 | 2.34 | 2.70 | 1.95 | 1.48 | 2.34 | 2.18 | 3.97 | 7.59 | ||||||||||||||
| Enterprise Value | 721.50M | 752.08M | 622.67M | 481.02M | 292.18M | 221.96M | 115.04M | 138.73M | 317.18M | 355.63M | 1,453.57M | 1,504.44M | 528.35M | 630.28M | 246.34M | 33.76M | 684.14M | 211.28M | 405.81M | 366.44M | ||||||||||||||
| EV to EBIT | -19.13 | -18.64 | -26.96 | -13.29 | -7.48 | -5.94 | -9.87 | -3.54 | -7.15 | -8.29 | -27.29 | -38.82 | -8.97 | -9.29 | -3.25 | -0.52 | -11.18 | -2.95 | -5.60 | -8.36 | ||||||||||||||
| EV to EBITDA | -19.13 | -18.64 | -26.96 | -13.29 | -7.48 | -5.94 | -9.87 | -3.54 | -7.15 | -8.29 | -27.29 | -38.82 | -8.97 | -9.29 | -3.25 | -0.52 | -11.18 | -2.95 | -5.60 | -8.36 | ||||||||||||||
| Market Capitalization | 938.06M | 925.35M | 933.35M | 749.92M | 508.94M | 385.33M | 497.80M | 482.08M | 625.01M | 612.47M | 1,693.91M | 2,263.98M | 1,235.31M | 1,288.81M | 834.37M | 550.36M | 809.47M | 578.71M | 706.52M | 568.07M | ||||||||||||||
| Price to FCFP/FCF | -24.61 | -23.97 | -86.88 | -20.95 | -14.56 | -10.36 | -32.75 | -10.45 | -14.72 | -14.69 | -64.38 | -55.13 | -23.80 | -14.93 | -17.01 | -6.57 | -10.11 | -8.00 | -10.63 | |||||||||||||||
| EV to FCF | -18.93 | -19.48 | -57.96 | -13.44 | -8.36 | -5.97 | -7.57 | -3.01 | -7.47 | -8.53 | -55.25 | -36.63 | -10.18 | -7.30 | -5.02 | -0.40 | -8.55 | -2.92 | -6.11 | |||||||||||||||
| EV to CFO | -19.71 | -21.64 | -67.99 | -13.73 | -9.48 | -6.96 | -7.90 | -3.27 | -8.31 | -8.85 | -58.53 | -37.13 | -10.34 | -8.21 | -6.49 | -0.45 | -9.40 | -3.11 | -6.03 | |||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,503.19% | -17,099.58% | -7,010.44% | -21,798.80% | -34,503.48% | -1,576.49% | -318.39% | -3,030.03% | -1,810.41% | -10,567.73% | -10,583.10% | -384.07% | -1,846.83% | -2,168.60% | -261,600.00% | -726.34% | -292.58% | -337.93% | -298.35% | -95.95% | ||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -53.73% | -59.22% | -43.73% | -38.59% | -45.71% | -54.26% | -37.57% | -29.21% | -31.98% | -35.31% | -51.94% | -30.17% | -23.17% | -27.77% | -32.43% | -38.39% | -40.60% | -45.03% | -49.01% | -52.74% | ||||||||||||||
| Return on Invested Capital [ROIC]ROIC | ||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -43.08% | -45.68% | -40.48% | -37.93% | -45.67% | -56.63% | -39.48% | -31.91% | -34.05% | -36.91% | -53.33% | -34.66% | -26.66% | -32.15% | -27.41% | -31.15% | -31.05% | -32.51% | -45.97% | -47.40% |